Cancer Communications
indexed by SCI
BMC

About the cover
About the cover

Nov. 2016; Volume 35 Issue 11

In November 2005, the first oncolytic virus, a genetically modified adenovirus, named H101 by Shanghai Sunway Biotech, gained regulatory approval from China's State Food and Drug Administration (SFDA) for the treatment of head and neck cancer.


Research Highlight
Treatment implications of posterior fossa ependymoma subgroups
Vijay Ramaswamy and Michael D. Taylor
[ Abstract  764]  [ PDF Full-text  1092]   [ HTML Full-text  651]    Epub: 2016-11-22  doi: DOI: 10.1186/s40880-016-0155-6
Induction chemotherapy for locoregionally advanced nasopharyngeal carcinoma
Wen-Fei Li, Lei Chen, Ying Sun and Jun Ma
[ Abstract  667]  [ PDF Full-text  1002]   [ HTML Full-text  695]    Epub: 2016-11-21  doi: 10.1186/s40880-016-0157-4
A combination therapy for KRAS-mutant lung cancer by targeting synthetic lethal partners of mutant KRAS
Xiufeng Pang and Mingyao Liu
[ Abstract  879]  [ PDF Full-text  1251]   [ HTML Full-text  678]    Epub: 2016-10-28  doi: 10.1186/s40880-016-0154-7
Review
What do oncologists need to know about biosimilar products?
Linda K. S. Leung, Kevin Mok, Calvin Liu and Stephen L. Chan
[ Abstract  1379]  [ PDF Full-text  1115]   [ HTML Full-text  484]    Epub: 2016-10-17  doi: 10.1186/s40880-016-0151-x
Original Article
Combined hepatocellular and cholangiocarcinoma originating from the same clone: a pathomolecular evidence-based study
Qian Zhao, Wen-Long Yu, Xin-Yuan Lu, Hui Dong, Yi-Jin Gu, Xia Sheng, Wen-Ming Cong and Meng-Chao Wu
[ Abstract  1330]  [ PDF Full-text  1730]   [ HTML Full-text  480]    Epub: 2016-8-24  doi: 10.1186/s40880-016-0146-7
Association of microRNA polymorphisms with the risk of head and neck squamous cell carcinoma in a Chinese population: a case–control study
Limin Miao, Lihua Wang, Longbiao Zhu, Jiangbo Du, Xun Zhu, Yuming Niu, Ruixia Wang, Zhibin Hu, Ning Chen, Hongbing Shen and Hongxia Ma
[ Abstract  926]  [ PDF Full-text  1535]   [ HTML Full-text  789]    Epub: 2016-8-11  doi: 10.1186/s40880-016-0136-9
Associations of genetic polymorphisms of the transporters organic cation transporter 2 (OCT2), multidrug and toxin extrusion 1 (MATE1), and ATP-binding cassette subfamily C member 2 (ABCC2) with platinum-based chemotherapy response and toxicity in non-small cell lung cancer patients
Chen-Yue Qian, Yi Zheng, Ying Wang, Juan Chen, Jun-Yan Liu, Hong-Hao Zhou, Ji-Ye Yin and Zhao-Qian Liu
[ Abstract  924]  [ PDF Full-text  1455]   [ HTML Full-text  754]    Epub: 2016-9-2  doi: 10.1186/s40880-016-0145-8
A model to predict the risk of lethal nasopharyngeal necrosis after re-irradiation with intensity-modulated radiotherapy in nasopharyngeal carcinoma patients
Ya-Hui Yu, Wei-Xiong Xia, Jun-Li Shi, Wen-Juan Ma, Yong Li, Yan-Fang Ye, Hu Liang, Liang-Ru Ke, Xing Lv, Jing Yang, Yan-Qun Xiang and Xiang Guo
[ Abstract  1441]  [ PDF Full-text  1371]   [ HTML Full-text  589]    Epub: 2016-6-29  doi: 10.1186/s40880-016-0124-0
Radiation-induced osteosarcoma of the maxilla and mandible after radiotherapy for nasopharyngeal carcinoma
Lie-Qiang Liao, Hong-Hong Yan, Jun-Hao Mai, Wei-Wei Liu, Hao Li, Zhu-Ming Guo, Zong-Yuan Zeng and Xue-Kui Liu
[ Abstract  854]  [ PDF Full-text  950]   [ HTML Full-text  729]    Epub: 2016-10-17  doi: 10.1186/s40880-016-0153-8
Case Report
Relapse of both small cell lung cancer and Lambert–Eaton myasthenic syndrome after a 13-year disease-free survival period
Fumio Asano, Keisuke Watanabe, Masaharu Shinkai, Yoshitaka Tei, Kei Mishina, Mikiko Tanabe, Hiroshi Ishii, Masahiro Shinoda, Tadasuke Shimokawaji, Makoto Kudo and Takeshi Kaneko
[ Abstract  1117]  [ PDF Full-text  1635]   [ HTML Full-text  1009]    Epub: 2016-7-2  doi: 10.1186/s40880-016-0127-x




CC Wechat 微信公众号

 

Editorial Manager


CC adopts Editorial Manager to manage its submissions from Dec.18, 2014
 

 

Reference style for  

 EndNote,
 Reference Manager



Editorial Manager


 

Year:

 

Month:

Advanced search

Subscription


CJC is now published by BioMed Central

© Chinese Journal of Cancer

Sun Yat-sen University Cancer Center

651 Dongfeng Road East, Guangzhou 510060, P. R. China